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ECONOMIC ANALYSIS AND HEALTH CARE
DECISIONS ISSUES
INTERPRETING AND USING COST·
EFFECTIVENESS RESULTS
Bala MV, Zarkin GA
Research Triangle Institute, Research Triangle Park, NC, USA
The objective of public policy decision making is to
choose the set of interventions that maximize the net ben-
efit to society. Given a set of mutually exclusive interven-
tions, the one with the lowest cost-effectiveness ratio is
not necessarily the one that maximizes net benefit. Thus,
a treatment with a higher cost-effectiveness ratio com-
pared to baseline may result in higher net benefits if its in-
cremental cost-effectiveness is less than the dollar value
of the outcome. In this presentation we describe how to
use cost-effectiveness results to determine the interven-
tion that maximizes net benefit. We also show how cost-
effectiveness results can be used to determine threshold
values for the benefit at which one intervention has a
higher net benefit than another. We then examine the ef-
fect of budget constraints on this decision making prob-
lem. We also present a graphical means of representing
cost-effectiveness results that allow for easy interpreta-
tion and use of the results. We describe a simple rule for
identifying the net benefit maximizing intervention from
this graph. We will illustrate the issues discussed using
examples from the medical literature. This workshop
should be beneficial to health care decision makers who
have to interpret cost-effectiveness results and incorpo-
rate them in their decision making process.
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DISSEMINATION OF PHARMACOECONOMIC
RESULTS TO MANAGED CARE
ORGANIZATIONS
Shreve JL, Pedlow KL, Marshall S, VanDenBos J
Milliman & Robertson, Inc., Denver, CO, USA
As the number of pharmacoeconomic studies has grown
over the past five years, the information contained in
these studies has not been consistently disseminated to
managed care organizations (MCOs). In addition to the
volume of these studies, many MCOs are not aware of
the standards to which such studies should be held. We
believe that these studies are best reviewed and dissemi-
nated by therapeutic class (or more narrowly). We will
present an example of such a review that includes (1) the
purpose of the study, (2) definitions and limitations of the
condition reviewed, (3) the considered included in the
study, (4) a listing and thorough review of all pharmaco-
Abstracts
economic studies (see below) considered, (5) statistical
tests relating to publication bias, (6) conclusions, includ-
ing economic consequences, recommended approaches,
and limitations, (7) the expected cost impact (per member
per month) on MCOs if the recommendation is adopted,
and (8) the sensitivity of the recommendation to the
prices of the alternative treatments. The thorough review
of each pharmacoeconomic study will further address is-
sues such as the perspective, alternatives, scientific rigor,
measurement variables, complications, quality of life
measures, time frame, and source of funding. To provide
further consistency, any assumptions made (such as dis-
count rate or cost of treatments) will be restated consis-
tently among the studies. We believe that these results,
consistently presented, will allow MCOs to make appro-
priate formulary and management decisions.
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OUTCOMES RESEARCH IN MEDICATION USE:
HCFA'S HEALTH CARE QUALITY
IMPROVEMENT PROGRAM
Westrick E
Rhode Island Quality Partners, Providence RI, USA
Outcomes research can be used to great advantage in
health care quality improvement efforts. The Health Care
Financing Administration (HCFA) has reengineered the
peer review program to follow this approach. The old
style of peer review largely relied upon case review, in
search of the "bad apple," a Quality Assurance (QA) ap-
proach. HCFA recognized that this approach created ad-
versarial relationships and did little to improve the qual-
ity of health care. The new approach to health care
quality improvement uses the principles of Continuous
Quality Improvement (CQI) and modern methods of
Outcomes Research to improve systems of care. HCFA
calls this the Health Care Quality Improvement Program
(HCQIP). Quality Improvement Organizations (QIOs)
work in all US states and territories to improve health
care for Medicare beneficiaries. These QIOs (formerly
called PROs or Peer Review Organizations) collaborate
with providers of health services, educational institutions,
departments of health, consumer groups, and industry in
projects designed to improve processes and outcomes of
care in selected disease states and clinical problem areas.
Many of these projects focus on medication use issues.
Examples of these projects will be presented to the audi-
ence. Participants will be made aware of opportunities to
collaborate on quality improvement projects at the state,
regional, and national levels. This workshop is designed
for individuals interested in improving health care
through Outcomes Research and Continuous Quality Im-
provement.
